|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ries LAG, Eisner MP, Kosary CL, Hankey BF,
Miller BA, Clegg LX and Edwards BK: SEER cancer statistics review,
1973-1998. National Institute of Health.
|
|
3
|
National Institute on Aging: Exploring the
role of cancer centers for integrating aging and cancer research
(workshop report). NIA, Bethesda, MD, 2002.
|
|
4
|
Ferlay J, Ervik M, Lam F, Colombet M, Mery
L, Piñeros M, Znaor A, Soerjomataram I and Bray F (eds): Cancer
Today (powered by GLOBOCAN 2018). World Health Organization and
International Agency for Research on Cancer, Lyon, 2018.
|
|
5
|
American Cancer Society: Global Cancer
Facts & Figures 4th Edition. Atlanta: American Cancer Society;
2018.
|
|
6
|
Imran A, Qamar HY, Ali Q, Naeem H, Riaz M,
Amin S, Kanwal N, Ali F, Sabar MF and Nasir IA: Role of molecular
biology in cancer treatment: A review article. Iran J Public
Health. 46:1475–1485. 2017.PubMed/NCBI
|
|
7
|
Hayes DF, Bast RC, Desch CE, Fritsche H
Jr, Kemeny NE, Jessup JM, Locker GY, Macdonald JS, Mennel RG,
Norton L, et al: Tumor marker utility grading system: A framework
to evaluate clinical utility of tumor markers. J Natl Cancer Inst.
88:1456–1466. 1996.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hayes DF: Prognostic and predictive
factors for breast cancer: Translating technology to oncology. J
Clin Oncol. 23:1596–1597. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Franceschi C, Garagnani P, Morsiani C,
Conte M, Santoro A, Grignolio A, Monti D, Capri M and Salvioli S:
The continuum of aging and age-related diseases: Common mechanisms
but different rates. Front Med (Lausanne). 5(61)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Colloca G, Di Capua B, Bellieni A, Fusco
D, Ciciarello F, Tagliaferri L, Valentini V and Balducci L:
Biological and functional biomarkers of aging: Definition,
characteristics, and how they can impact everyday cancer treatment.
Curr Oncol Rep. 22:1–21. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Guo J, Huang X, Dou L, Yan M, Shen T, Tang
W and Li J: Aging and aging-related diseases: From molecular
mechanisms to interventions and treatments. Signal Transduct Target
Ther. 7(391)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kennedy BK, Berger SL, Brunet A, Campisi
J, Cuervo AM, Epel ES, Franceschi C, Lithgow GJ, Morimoto RI,
Pessin JE, et al: Geroscience: Linking aging to chronic disease.
Cell. 159:709–713. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sharma G and Goodwin J: Effect of aging on
respiratory system physiology and immunology. Clin Interv Aging.
1:253–260. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vaiserman A and Krasnienkov D: Telomere
length as a marker of biological age: State-of-the-art, open
issues, and future perspectives. Front Genet.
11(630186)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
White MC, Holman DM, Boehm JE, Peipins LA,
Grossman M and Henley SJ: Age and cancer risk: A potentially
modifiable relationship. Am J Prev Med. 46:S7–S15. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li Z, Zhang Z, Ren Y, Wang Y, Fang Y, Yue
H, Ma S and Guan F: Aging and age-related diseases: From mechanisms
to therapeutic strategies. Biogerontology. 22:165–187.
2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Economopoulou P, de Bree R, Kotsantis I
and Psyrri A: Diagnostic tumor markers in head and neck squamous
cell carcinoma (HNSCC) in the clinical setting. Front Oncol.
9(827)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
National Research Council (US) Panel on
Statistics for an Aging Population Dorothy M. Gilford, editors: The
aging population in the twenty-first century: Statistics for health
policy. Washington (DC): National Academies Press (US); ISBN-10:
0-309-03881-2, 1988.
|
|
19
|
Aunan JR, Cho WC and Søreide K: The
biology of aging and cancer: A brief overview of shared and
divergent molecular hallmarks. Aging Dis. 8:628–642.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cavalieri TA, Chopra A and Bryman PN: When
outside the norm is normal: Interpreting lab data in the aged.
Geriatrics. 47:66–70. 1992.PubMed/NCBI
|
|
21
|
Wilson J, Heinsch M, Betts D, Booth D and
Kay-Lambkin F: Barriers and facilitators to the use of e-health by
older adults: A scoping review. BMC Public Health.
21(1556)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Campisi J: Aging, cellular senescence, and
cancer. Annu Rev Physiol. 75:685–705. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shir D, Mielke MM, Hofrenning EI, Lesnick
TG, Knopman DS, Petersen RC, Jack CR, Algeciras-Schimnich A, Vemuri
P and Graff-Radford J: Associations of neurodegeneration biomarkers
in cerebrospinal fluid with markers of Alzheimer's disease and
vascular pathology. J Alzheimer Dis. 92:887–898. 2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tran KA, Kondrashova O, Bradley A,
Williams ED, Pearson JV and Waddell N: Deep learning in cancer
diagnosis, prognosis and treatment selection. Genome Med. 13:1–7.
2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kiely M, Tse LA, Koka H, Wang D, Lee P,
Wang F, Wu C, Tsang KH, Chan WC, Law SH, et al: Age-related DNA
methylation in paired normal and tumor breast tissue in Chinese
breast cancer patients. Epigenetics. 16:677–691. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mealey NE, O'Sullivan DE, Pader J, Ruan Y,
Wang E, Quan ML and Brenner DR: Mutational landscape differences
between young-onset and older-onset breast cancer patients. BMC
Cancer. 20(212)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Azim HA Jr, Nguyen B, Brohée S, Zoppoli G
and Sotiriou C: Genomic aberrations in young and elderly breast
cancer patients. BMC Med. 13(266)2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
De Kruijf EM, Bastiaannet E, Rubertá F, de
Craen AJ, Kuppen PJ, Smit VT, van de Velde CJ and Liefers GJ:
Comparison of frequencies and prognostic effect of molecular
subtypes between young and elderly breast cancer patients. Mol
Oncol. 8:1014–1025. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang MX, Ren JT, Tang LY and Ren ZF:
Molecular features in young vs elderly breast cancer patients and
the impacts on survival disparities by age at diagnosis. Cancer
Med. 7:3269–3277. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhong W, Zhao J, Huang K, Zhang J and Chen
Z: Comparison of clinicopathological and molecular features between
young and old patients with lung cancer. Int J Clin Exp Pathol.
11:1031–1035. 2018.PubMed/NCBI
|
|
31
|
Lin C, Chen X, Li M, Liu J, Qi X, Yang W,
Zhang H, Cai Z, Dai Y and Ouyang X: Programmed death-ligand 1
expression predicts tyrosine kinase inhibitor response and better
prognosis in a cohort of patients with epidermal growth factor
receptor mutation-positive lung adenocarcinoma. Clin Lung Cancer.
16:e25–e35. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Boldrini L, Giordano M, Lucchi M, Melfi F
and Fontanini G: Expression profiling and microRNA regulation of
the LKB1 pathway in young and aged lung adenocarcinoma patients.
Biomed Rep. 29:198–205. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pettersson A, Robinson D, Garmo H,
Holmberg L and Stattin P: Age at diagnosis and prostate cancer
treatment and prognosis: A population-based cohort study. Ann
Oncol. 29:377–385. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang H, Messing EM, Travis LB, Hyrien O,
Chen R, Milano MT and Chen Y: Age and racial differences among
PSA-detected (AJCC stage T1cN0M0) prostate cancer in the U.S.: A
population-based study of 70,345 men. Front Oncol.
3(312)2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Calvocoressi L, Uchio E, Ko J,
Radhakrishnan K, Aslan M and Concato J: Prostate cancer
aggressiveness and age: Impact of p53, BCL-2 and microvessel
density. J Investig Med. 66:1142–1146. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Aparicio T, Schischmanoff O, Poupardin C,
Soufir N, Angelakov C, Barrat C, Levy V, Choudat L, Cucherousset J,
Boubaya M, et al: Deficient mismatch repair phenotype is a
prognostic factor for colorectal cancer in elderly patients. Dig
Liver Dis. 45:245–250. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Phipps AI, Buchanan DD, Makar KW,
Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ,
Win AK, Potter JD and Newcomb PA: BRAF mutation status and survival
after colorectal cancer diagnosis according to patient and tumor
characteristics. Cancer Epidemiol Biomarkers Prev. 21:1792–1798.
2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lodi M, Scheer L, Reix N, Heitz D, Carin
AJ, Thiébaut N, Neuberger K, Tomasetto C and Mathelin C: Breast
cancer in elderly women and altered clinico-pathological
characteristics: A systematic review. Breast Cancer Res Treat.
166:657–668. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Velcheti V, Schalper KA, Carvajal DE,
Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L
and Rimm DL: Programmed death ligand-1 expression in non-small cell
lung cancer. Lab Invest. 94:107–116. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Brody R, Zhang Y, Ballas M, Siddiqui MK,
Gupta P, Barker C, Midha A and Walker J: PD-L1 expression in
advanced NSCLC: Insights into risk stratification and treatment
selection from a systematic literature review. Lung Cancer.
112:200–215. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Jędroszka D, Orzechowska M, Hamouz R,
Górniak K and Bednarek AK: Markers of epithelial-to-mesenchymal
transition reflect tumor biology according to patient age and
Gleason score in prostate cancer. PLoS One.
12(e0188842)2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sacher AG, Dahlberg SE, Heng J, Mach S,
Jänne PA and Oxnard GR: Association between younger age and
targetable genomic alterations and prognosis in non-small-cell lung
cancer. JAMA Oncol. 2:313–320. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Van Herck Y, Feyaerts A, Alibhai S,
Papamichael D, Decoster L, Lambrechts Y, Pinchuk M, Bechter O,
Herrera-Caceres J, Bibeau F, et al: Is cancer biology different in
older patients? Lancet Healthy Longev. 2:e663–e677. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Hasan N, Choudhary S, Naaz N, Sharma N and
Laskar RA: Recent advancements in molecular marker-assisted
selection and applications in plant breeding programmes. J Genet
Eng Biotechnol. 19(128)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhu L, Zhao L, Wang Q, Zhong S, Guo X, Zhu
Y, Bao J, Xu K and Liu S: Circulating exosomal miRNAs and cancer
early diagnosis. Clin Transl Oncol. 24:393–406. 2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chakravarty D, Johnson A, Sklar J,
Lindeman NI, Moore K, Ganesan S, Lovly CM, Perlmutter J, Gray SW,
Hwang J, et al: Somatic genomic testing in patients with metastatic
or advanced cancer: ASCO provisional clinical opinion. J Clin
Oncol. 40:1231–1258. 2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Shaw AT, Ou SHI, Bang YJ, Camidge DR,
Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa
DB, et al: Crizotinib in ROS1-rearranged non-small-cell lung
cancer. N Engl J Med. 371:1963–1971. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Subbiah V, Lassen U, Elez E, Italiano A,
Curigliano G, Javle M, de Braud F, Prager GW, Greil R, Stein A, et
al: Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated
biliary tract cancer (ROAR): A phase 2, open-label, single-arm,
multicentre basket trial. Lancet Oncol. 21:1234–1243.
2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Swetter SM, Thompson JA, Albertini MR,
Barker CA, Baumgartner J, Boland G, Chmielowski B, DiMaio D, Durham
A, Fields RC, et al: NCCN guidelines® insights:
Melanoma: Cutaneous, version 2.2021. J Natl Compr Canc Netw.
19:364–376. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Douillard JY, Oliner KS, Siena S,
Tabernero J, Burkes R, Barugel M, Humblet Y, Bodoky G, Cunningham
D, Jassem J, et al: Panitumumab-FOLFOX4 treatment and RAS mutations
in colorectal cancer. N Engl J Med. 369:1023–1034. 2013.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ray-Coquard I, Pautier P, Pignata S, Pérol
D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N,
Mäenpää J, et al: Olaparib plus bevacizumab as first-line
maintenance in ovarian cancer. N Engl J Med. 381:2416–2428.
2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Battaglin F, Naseem M, Puccini A and Lenz
HJ: Molecular biomarkers in gastro-esophageal cancer: Recent
developments, current trends and future directions. Cancer Cell
Int. 18(99)2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Olson SH, Atoria CL, Cote ML, Cook LS,
Rastogi R, Soslow RA, Brown CL and Elkin EB: The impact of race and
comorbidity on survival in endometrial cancer. Cancer Epidemiol
Biomarkers Prev. 21:753–760. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
US Food and Drug Administration: FDA
grants accelerated approval to erdafitinib for metastatic
urothelial carcinoma, 2021. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-erdafitinib-metastatic-urothelial-carcinoma.
|
|
55
|
Javle MM, Roychowdhury S, Kelley RK,
Sadeghi S, Macarulla T, Waldschmidt DT, Goyal L, Borbath I,
El-Khoueiry AB, Yong WP, et al: Final results from a phase II study
of infigratinib (BGJ398), an FGFR-selective tyrosine kinase
inhibitor, in patients with previously treated advanced
cholangiocarcinoma harboring an FGFR2 gene fusion or rearrangement.
J Clin Oncol. 39(265)2021.
|
|
56
|
Martin GM: Proliferative homeostasis and
its age-related aberrations. Mech Ageing Dev. 9:385–391.
1979.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Atillasoy E and Holt PR: Gastrointestinal
proliferation and aging. J Gerontol. 48:B43–B49. 1993.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Nagayo T: Gastric cancer preceded by
severe dysplasia. Histol Histopatnol. l:171–80. 1986.PubMed/NCBI
|
|
59
|
You WC, Blot WJ, Li JY, Chang YS, Jin ML,
Kneller R, Zhang L, Han ZX, Zeng XR and Liu WD: Precancerous
gastric lesions in a population at high risk of stomach cancer.
Cancer Res. 53:1317–1321. 1993.PubMed/NCBI
|
|
60
|
Lopez LA, Villar VD, Ulla M, Fernandez F,
Fernandez LA, Santos I, Rabadan L and Gutierrez M: Prevalence of
abnormal levels of serum tumor markers in elderly people. Age
Ageing. 25:45–50. 1996.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Cohen HJ, Harris T and Pieper CF:
Coagulation and activation of inflammatory pathways in the
development of functional decline and mortality in the elderly. Am
J Med. 114:180–187. 2003.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Jencks DS, Adam JD, Borum ML, Koh JM,
Stephen S and Doman DB: Overview of current concepts in gastric
intestinal metaplasia and gastric cancer. Gastroenterol Hepatol (N
Y). 14:92–101. 2018.PubMed/NCBI
|
|
63
|
Owusu C and Berger NA: Comprehensive
geriatric assessment in the older cancer patient: Coming of age in
clinical cancer care. Clin Pract (Lond). 11:749–762.
2014.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Balducci L and Extermann M: Management of
cancer in the older person: A practical approach. Oncologist.
5:224–237. 2000.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Sarhadi VK and Armengol G: Molecular
biomarkers in cancer. Biomolecules. 12(1021)2022.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Pal M, Muinao T, Boruah HPD and Mahindroo
N: Current advances in prognostic and diagnostic biomarkers for
solid cancers: Detection techniques and future challenges. Biomed
Pharmacother. 146(112488)2022.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Usman S, Jamal A, The MT and Waseem A:
Major molecular signaling pathways in oral cancer associated with
therapeutic resistance. Front Oral Health. 1(603160)2021.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Pan MR, Li K, Lin SY and Hung WC:
Connecting the dots: From DNA damage and repair to aging. Int J Mol
Sci. 17(685)2016.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Weichhart T: mTOR as regulator of
lifespan, aging, and cellular senescence: A mini-review.
Gerontology. 64:127–134. 2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Lee SH, Lee JH, Lee HY and Min KJ: Sirtuin
signaling in cellular senescence and aging. BMB Rep. 52:24–34.
2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Tomasetti C and Vogelstein B: Variation in
cancer risk among tissues can be explained by the number of stem
cell divisions. Science. 347:78–81. 2015.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Zheng PP, Li J and Kros JM: Breakthroughs
in modern cancer therapy and elusive cardiotoxicity: Critical
research-practice gaps, challenges, and insights. Med Res Rev.
38:325–376. 2018.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Li Y, Li M, Zhang Y, Zhou J, Jiang L, Yang
C, Li G, Qu W, Li X and Chen Y: Age-stratified and gender-specific
reference intervals of six tumor markers panel of lung cancer: A
geographic-based multicenter study in China. J Clin Lab Anal.
35(e23816)2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Desouki MM, Fadare O, Chamberlain B,
Shakir N and Kanbour-Shakir A: Malignancy associated with ovarian
teratomas: Frequency, histotypes, and diagnostic accuracy of
intraoperative consultation. Ann Diagn Pathol. 19:103–106.
2015.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Hackethal A, Brueggmann D, Bohlmann MK,
Franke FE, Tinneberg HR and Münstedt K: Squamous-cell carcinoma in
mature cystic teratoma of the ovary: Systematic review and analysis
of published data. Lancet Oncol. 9:1173–1180. 2008.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Yamanaka Y, Tateiwa Y, Miyamoto H, Umemoto
Y, Takeuchi Y, Katayama K and Hashimoto K: Preoperative diagnosis
of malignant transformation in mature cystic teratoma of the ovary.
Eur J Gynaecol Oncol. 26:391–392. 2005.PubMed/NCBI
|
|
77
|
Mahtate M, Talib S, Slaoui A, Zeraidi N,
Lakhdar A, Rhrab B and Baydada A: Malignant degeneration of a
mature ovarian teratoma. Case Rep Obstet Gynecol.
2021(5527467)2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Dede M, Gungor S, Yenen MC, Alanbay I,
Duru NK and Haşimi A: CA19-9 may have clinical significance in
mature cystic teratomas of the ovary. Int J Gynecol Cancer.
16:189–193. 2006.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Frimer M, Seagle BL, Chudnoff S, Goldberg
GL and Shahabi S: Role of elevated cancer antigen 19-9 in women
with mature cystic teratoma. Reprod Sci. 21:1307–1311.
2014.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Yesilyurt H, Seckin B, Aktulay A and Ozyer
S: Age-stratified analysis of tumor markers and tumor
characteristics in adolescents and young women with mature cystic
teratoma. J Chin Med Assoc. 81:499–504. 2018.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Starkweather AR, Alhaeeri AA, Montpetit A,
Brumelle J, Filler K, Montpetit M, Mohanraj L, Lyon DE and
Jackson-Cook CK: An integrative review of factors associated with
telomere length and implications for biobehavioral research. Nurs
Res. 63:36–50. 2018.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Fasching CL: Telomere length measurement
as a clinical biomarker of aging and disease. Crit Rev Clin Lab
Sci. 55:443–465. 2018.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Limanaqi F, Biagioni F, Gambardella S,
Familiari P, Frati A and Fornai F: Promiscuous roles of autophagy
and proteasome in neurodegenerative proteinopathies. Int J Mol Sci.
24(3028)2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Kumari R and Jat P: Mechanisms of cellular
senescence: Cell cycle arrest and senescence associated secretory
phenotype. Front Cell Dev Biol. 9(645593)2021.PubMed/NCBI View Article : Google Scholar
|
